AAL
32
3
NTAP
67
2
EQIX
45
-2
CFG
46
-2
EXPE
69
2
LRCX
77
6
NAVI
33
-5
FMC
29
-2
DNB
34
-4
PPL
52
-5
JCI
32
-3
VTR
55
-6
WBA
31
-4
VFC
57
-5
PH
62
-2
URI
66
-2
KEY
43
-3
ICE
64
-3
WEC
46
-4
MTCH
53
-2
AAL
32
3
NTAP
67
2
EQIX
45
-2
CFG
46
-2
EXPE
69
2
LRCX
77
6
NAVI
33
-5
FMC
29
-2
DNB
34
-4
PPL
52
-5
JCI
32
-3
VTR
55
-6
WBA
31
-4
VFC
57
-5
PH
62
-2
URI
66
-2
KEY
43
-3
ICE
64
-3
WEC
46
-4
MTCH
53
-2
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

The Next Nvidia?

Go here now for this breaking story.
Buy
75

VRNA
Verona Pharma PLC

Last Price:
15.04
Seasonality Move:
8.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Jeff Bezos's Plan Exposed

And for investors who get in now profits could be massive - click here for full story.

Verona Pharma PLC Price Quote

$15.04

Verona Pharma PLC Key Stats

Buy
75
Verona Pharma PLC (VRNA) is a Buy
Day range:
$14.80 - $15.96
52-week range:
$11.39 - $23.07
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.42%
Volume:
2.3M
Avg. volume:
1.1M
1-year change:
-30.11%
Market cap:
$1.2B
Revenue:
$0
EPS:
$-0.8

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

  • How Much Debt Does Verona Pharma PLC Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Verona Pharma PLC Have?
    Cash and short term investments quarterly total is $254.9M
  • What Is Verona Pharma PLC’s Book Value Per Share?
    Book value per share is 2.78

Is Verona Pharma PLC Cash Flow Positive?

  • What Is VRNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.1M
  • What Is Verona Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $21.1M
  • What Is Verona Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$16K

Verona Pharma PLC Return On Invested Capital

Data Unavailable

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Bicycle Therapeutics PLC (BCYC)
    • Biodexa Pharmaceuticals Plc (BDRX)
    • Mereo BioPharma Group PLC (MREO)
    • NuCana PLC (NCNA)

Verona Pharma PLC Dividend Yield

Data Unavailable

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 69.57%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.29
Upside from Last Price: 127.96%

Major Shareholders

  • How many VRNA shares are owned by institutional investors?
    85.2M VRNA shares are owned by institutional investors
  • How many VRNA shares are owned by insiders?
    42.2M VRNA shares are owned by insiders